241 related articles for article (PubMed ID: 18560219)
1. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices.
Savitz SI; Benatar M; Saver JL; Fisher M
Cerebrovasc Dis; 2008; 26(2):156-62. PubMed ID: 18560219
[TBL] [Abstract][Full Text] [Related]
2. Percent change on the National Institutes of Health Stroke Scale: a useful acute stroke outcome measure.
Bruno A; Saha C; Williams LS
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):56-9. PubMed ID: 19110146
[TBL] [Abstract][Full Text] [Related]
3. Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7.
Hallevi H; Albright KC; Martin-Schild SB; Barreto AD; Morales MM; Bornstein N; Ifejika NL; Shuaib A; Grotta JC; Savitz SI;
Cerebrovasc Dis; 2009; 28(4):341-8. PubMed ID: 19628935
[TBL] [Abstract][Full Text] [Related]
4. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
[TBL] [Abstract][Full Text] [Related]
5. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke.
Saver JL
Arch Neurol; 2004 Jul; 61(7):1066-70. PubMed ID: 15262737
[TBL] [Abstract][Full Text] [Related]
6. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
Savitz SI; Fisher M
Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
[TBL] [Abstract][Full Text] [Related]
7. Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes.
Lyden P; Claesson L; Havstad S; Ashwood T; Lu M
Arch Neurol; 2004 Nov; 61(11):1677-80. PubMed ID: 15534178
[TBL] [Abstract][Full Text] [Related]
8. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
Savitz SI
Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618
[TBL] [Abstract][Full Text] [Related]
9. Perspectives on neuroprotective stroke therapy.
Schäbitz WR; Fisher M
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1271-6. PubMed ID: 17073800
[TBL] [Abstract][Full Text] [Related]
10. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.
Lampl Y; Boaz M; Gilad R; Lorberboym M; Dabby R; Rapoport A; Anca-Hershkowitz M; Sadeh M
Neurology; 2007 Oct; 69(14):1404-10. PubMed ID: 17909152
[TBL] [Abstract][Full Text] [Related]
11. Edaravone - citicoline comparative study in acute ischemic stroke (ECCS-AIS).
Mitta M; Goel D; Bansal KK; Puri P
J Assoc Physicians India; 2012 Nov; 60():36-8. PubMed ID: 23767201
[TBL] [Abstract][Full Text] [Related]
12. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
[TBL] [Abstract][Full Text] [Related]
13. [Past, present and future of neuroprotection].
Mracek J
Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
[TBL] [Abstract][Full Text] [Related]
14. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
15. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
[TBL] [Abstract][Full Text] [Related]
16. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial.
LaMonte MP; Bahouth MN; Magder LS; Alcorta RL; Bass RR; Browne BJ; Floccare DJ; Gaasch WR;
Ann Emerg Med; 2009 Sep; 54(3):319-27. PubMed ID: 19101059
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in pharmacologic neuroprotection.
Mantz J; Degos V; Laigle C
Eur J Anaesthesiol; 2010 Jan; 27(1):6-10. PubMed ID: 19617840
[TBL] [Abstract][Full Text] [Related]
18. Outcome measurements in scleroderma: results from a delphi exercise.
Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR
J Rheumatol; 2007 Mar; 34(3):501-9. PubMed ID: 17299843
[TBL] [Abstract][Full Text] [Related]
19. IV t-PA therapy in acute stroke patients with atrial fibrillation.
Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Yamashita S; Aoki J
J Neurol Sci; 2009 Jan; 276(1-2):6-8. PubMed ID: 19010485
[TBL] [Abstract][Full Text] [Related]
20. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]